In COPD patients, the inflammatory immune response is altered, and often involves increased cytokines, including IFN-γ, CXCL9 (MIG), CXCL10 (IP-10), and CCL5 (RANTES) [14–16]. This evidence concerns the gene CXCL9 and chronic obstructive pulmonary disease.